Hodgkin Disease
General Information
A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND#117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (CHL) in Children and Adolescents
Pediatrics
AHOD1331
Inova Children's Hospital
3300 Gallows Road
Falls Church, VA 22042
Eligibility Information
Ineligibility Information